Literature DB >> 33230857

No SARS-CoV-2 carriage observed in children attending daycare centers during the intial weeks of the epidemic in Belgium.

Stefanie Desmet1, Esra Ekinci2, Ine Wouters2, Bram Decru1, Kurt Beuselinck3, Surbhi Malhotra-Kumar4, Heidi Theeten2.   

Abstract

To gain knowledge about the role of young children attending daycare in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic, a random sample of children (n = 84) aged between 6 and 30 months attending daycare in Belgium was studied shortly after the start of the epidemic (February 29th) and before the lockdown (March 18th) by performing in-house SARS-CoV-2 real-time polymerase chain reaction. No asymptomatic carriage of SARS-CoV-2 was detected, whereas common cold symptoms were common (51.2%). Our study shows that in Belgium, there was no sign of early introduction into daycare centers at the moment children being not yet isolated at home, although the virus was clearly circulating. It is clear that more evidence is needed to understand the actual role of young children in the transmission of SARS-CoV-2 and their infection risk when attending daycare.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; SARS-COV-2; carriage; children; daycare

Mesh:

Year:  2020        PMID: 33230857      PMCID: PMC7753838          DOI: 10.1002/jmv.26689

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   20.693


INTRODUCTION

In December 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) had emerged in Wuhan, China, causing the 2019 novel coronavirus disease (COVID‐19). This virus eventually had spread worldwide, and in March 2020, the World Health Organization announced SARS‐CoV‐2, a pandemic health emergency. Person‐to‐person transmission of SARS‐CoV‐2 takes place mainly through close contact with an infected person (mainly via respiratory droplets) and after touching infected objects. Most common clinical manifestations of SARS‐CoV‐2 are fever, dry cough, shortness of breath, and respiratory failure and vary from very mild to severe symptoms. Other symptoms in children are diarrhea, nausea/vomiting, fatigue, and abdominal pain. , , Recently, in the United States, England, Italy, and France, rare cases with symptoms of Kawasaki‐like multisystem inflammatory syndrome were reported. , , , Current evidence indicates that older populations are most susceptible to severe presentations of COVID‐19; however, there is less knowledge about disease severity and transmission among infants and children. Evidence in China suggests that the clinical symptoms of COVID‐19 may be less severe in children and thus harder to recognize. , Possible explanations could be: (1) children might have fewer opportunities for exposure to pathogens or infected patients, (2) lower expression of the angiotensin‐converting enzyme II (ACE2) receptor as it is indicated that ACE2 is likely the receptor for SARS‐CoV‐2, (3) children often get respiratory infections (including coronaviruses) in the winter and might therefore have higher antibody levels than adults, (4) the immune system of children is still developing and may react differently on pathogens compared to adults' immune system. The lower symptomatic disease incidence in the pediatric population raises the concern that this population could be an important source of SARS‐CoV‐2 transmission. Understanding the burden of carriage in children and the subsequent potential for transmission of severe acute respiratory syndrome‐associated coronavirus (SARS‐CoV‐2), it is important to implement public health measures and to decide on the exit strategy for the current lockdown in Belgium. This study investigated the (asymptomatic) carriage of SARS‐CoV‐2 in children attending daycare centers (DCCs) during the period March 2–12, 2020, to get more insight into the possible role of children in the transmission of SARS‐CoV‐2 during the intial weeks of the SARS‐CoV‐2 epidemic in Belgium. Although the first confirmed case was on February 4th, 2020, the real start of the epidemic was detected from February 29th onwards, with a total of 689 confirmed cases spread over the whole country on March 13th. Early March, Belgium had a massive introduction of travelers with COVID‐19, which was just at the start of the Southern European epidemic. Contrary to the expectations and observations in other countries, Belgian case data and the results of a seroprevalence study (week March 30) underline the scattered spread of COVID‐19 all over the country during the intial weeks of March. Due to the restricted testing at that moment, no reliable Belgian incidence rates are available for March 2020, but seroprevalence of SARS‐CoV‐2 IgG was 2.9% at the end of March.

MATERIAL AND METHODS

Ethical statement

The current study was in line with the Declaration of Helsinki, as revised in 2013. Approval to conduct the current study with ID 18/31/355 was obtained from the University of Antwerp and University Hospital of Antwerp ethics committee (Commissie voor Medische Ethiek van UZA/UA) on 29/07/2019. Informed consent allowed us to determine other respiratory pathogens.

Study population and sampling

The current study was embedded in the nasopharyngeal (NP) carriage study that started in Belgium in 2016 to monitor changes in the proportions of pneumococcal serotypes in children between six and thirty months of age attending DCCs. DCCs were randomly selected throughout Belgium. After written consent of at least one parent, a single NP swab (pediatric flocked swab (Copan®)) was collected. A questionnaire regarding the child's demographic and clinical characteristics, as well as pneumococcal vaccination status, was filled in by their parents. Signs of the common cold in children were defined as coughing and/or running nose and were registered at the moment of sampling. Sample collection during 2019–2020 was performed from the beginning of November 2019 to the end of March 2020. This collection period spanned the crucial first weeks of the COVID‐19 epidemic in Belgium, thus enabling us to study the introduction, if any, of the SARS‐CoV‐2 virus in the daycare population. To determine the SARS‐CoV‐2 carriage, NP swabs taken from 84 children attending eight different DCCs spread over 6 of the 10 Belgian provinces (namely three in East Flanders, one in Antwerp, one in Brussels, one in Liège, one in Walloon Brabant, and one in Luxemburg) during the period of March 2–12, 2020 were analyzed. Of the 84 children included in this study, relevant population characteristics were: (1) 43 (52.4%) were girls; (2) at the moment of sampling, signs of common cold were observed in half of the children (51.2%); (3) just over half (56.1%) of the children had at least one sibling in the same household; (4) the majority of children (87.8%) stayed at least twice a week in daycare; and (5) the parents of the majority of the children (75.6%) were nonsmokers.

In‐house SARS‐CoV‐2 real‐time polymerase chain reaction (PCR)

The collected swabs were transported on dry ice and stored in 1 ml STGG (skim milk, tryptone, glucose, glycerol). In‐house SARS‐CoV‐2 real‐time PCR targeting the E gene, making use of primers adapted from Corman et al. was performed on 200 µl of the sample. The limit of detection of this PCR is 50 copies/ml and validation of this PCR indicated a 100% sensitivity taking results of Xpert Xpress SARS‐CoV‐2 and Hologic Aptima SARS‐CoV‐2 as the golden standard. Validation of the test on STGG medium was performed by adding 3 µl of COVID‐19‐positive sample (n = 3) to 300 µl STGG media, followed by storage in a refrigerator (4°C) for 24 h and afterward freezing at −80°C. C t‐values of the frozen STGG samples were similar to the C t‐values of the initial sample (1/100 diluted).

RESULTS

All analyzed samples were negative for SARS‐CoV‐2, which means that shortly after the start of the epidemic (February 29th) and before the lockdown in Belgium (March 18th) no (asymptomatic) carriage of SARS‐CoV‐2 was detected in a random sample of children (n = 84) aged between 6 and 30 months attending daycare. Only one sample had an amplification curve (C t value of 38.8). To confirm this weak signal, the extract of this sample was reanalyzed in triple and no amplification was observed. A limitation of our study is that we have no information on COVID‐19‐like symptoms in household members or caregivers.

DISCUSSION

The result is in line though with other studies that suggest only a minimal role of children in the epidemic of SARS‐CoV‐2. Iceland reported children under 10 years of age less likely to be positive by reverse transcriptase‐PCR testing than were persons 10 years of age or older in large‐scale screening in a random sample of the general population (n = 13,080 of whom 848 children were all negative vs. 0.8% positives in the remaining sample). Similarly, in Italy no children younger than 10 were infected in a large‐scale survey before and after the start of the lockdown in the municipality where the first COVID‐19 death in Italy was reported. Among confirmed COVID‐19 patients, the percentage of children, was as low as 1–5% in studies published up to March 18, 2020, and in the United States up to April 10. , Although children in China had a similar risk of infection as adults, China reported a lower secondary attack rate to children than to adults (4% vs. 17%) in a household study. Only a handful of deaths among children with COVID‐19 have been reported worldwide, and generally, symptoms in children are mild. Limited evidence from contact research suggests that children less frequently infect other people than do adults, although similar viral loads as in adults were observed in an unpublished German study. In the Netherlands, a household study showed that the spread of SARS‐CoV‐2 occurs mainly between people of approximately the same age, and that patients under 20 years of age had a smaller impact on the spread of the virus compared to adults. A recent review found only 9.7% pediatric index cases among 31 intra‐household transmission clusters identified from the literature. These findings were supported by data from Guangzhou. They found even lower rate of children (around 5%) as index cases in households. A case study of a cluster in France showed that there was no transmission from a COVID‐19‐positive child to any other person after exposure to more than a hundred children. In Austria, 735 students and 128 staff were in close contact with nine children and nine adult school cases; here again, no transmission from the cases to other people was observed. Our study adds that in Belgium, where the epidemic was imported mainly by adult travelers, there was no sign of early introduction into DCCs at the moment children being not yet isolated at home, although the virus was introduced widespread, and immediately circulating according to case‐based and seroprevalence data. It is clear that more evidence is needed to understand the actual role of young children in the transmission of SARS‐CoV‐2 and their infection risk when attending daycare.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

AUTHOR CONTRIBUTIONS

All authors contributed to study design and implementation. Esra Ekinci, Ine Wouters, and Heidi Theeten initiated, and Stefanie Desmet and Surbhi Malhotra‐Kumar reviewed the manuscript.
  23 in total

1.  Epidemiology of COVID-19 Among Children in China.

Authors:  Yuanyuan Dong; Xi Mo; Yabin Hu; Xin Qi; Fan Jiang; Zhongyi Jiang; Shilu Tong
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

2.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

3.  Hyperinflammatory shock in children during COVID-19 pandemic.

Authors:  Shelley Riphagen; Xabier Gomez; Carmen Gonzalez-Martinez; Nick Wilkinson; Paraskevi Theocharis
Journal:  Lancet       Date:  2020-05-07       Impact factor: 79.321

4.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study.

Authors:  Qifang Bi; Yongsheng Wu; Shujiang Mei; Chenfei Ye; Xuan Zou; Zhen Zhang; Xiaojian Liu; Lan Wei; Shaun A Truelove; Tong Zhang; Wei Gao; Cong Cheng; Xiujuan Tang; Xiaoliang Wu; Yu Wu; Binbin Sun; Suli Huang; Yu Sun; Juncen Zhang; Ting Ma; Justin Lessler; Tiejian Feng
Journal:  Lancet Infect Dis       Date:  2020-04-27       Impact factor: 25.071

5.  Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.

Authors:  Julie Toubiana; Clément Poirault; Alice Corsia; Fanny Bajolle; Jacques Fourgeaud; François Angoulvant; Agathe Debray; Romain Basmaci; Elodie Salvador; Sandra Biscardi; Pierre Frange; Martin Chalumeau; Jean-Laurent Casanova; Jérémie F Cohen; Slimane Allali
Journal:  BMJ       Date:  2020-06-03

6.  Seroprevalence of IgG antibodies against SARS-CoV-2 - a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020.

Authors:  Sereina Annik Herzog; Jessie De Bie; Steven Abrams; Ine Wouters; Esra Ekinci; Lisbeth Patteet; Astrid Coppens; Sandy De Spiegeleer; Philippe Beutels; Pierre Van Damme; Niel Hens; Heidi Theeten
Journal:  Euro Surveill       Date:  2022-03

7.  Clinical manifestations of children with COVID-19: A systematic review.

Authors:  Tiago H de Souza; José A Nadal; Roberto J N Nogueira; Ricardo M Pereira; Marcelo B Brandão
Journal:  Pediatr Pulmonol       Date:  2020-06-15

8.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.

Authors:  Lucio Verdoni; Angelo Mazza; Annalisa Gervasoni; Laura Martelli; Maurizio Ruggeri; Matteo Ciuffreda; Ezio Bonanomi; Lorenzo D'Antiga
Journal:  Lancet       Date:  2020-05-13       Impact factor: 79.321

9.  How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018.

Authors:  Ine Wouters; Stefanie Desmet; Liesbet Van Heirstraeten; Sereina A Herzog; Philippe Beutels; Jan Verhaegen; Herman Goossens; Pierre Van Damme; Surbhi Malhotra-Kumar; Heidi Theeten
Journal:  Euro Surveill       Date:  2020-02
View more
  11 in total

1.  Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022.

Authors:  Liesbet Van Heirstraeten; Esra Ekinci; Mathias Smet; Matilda Berkell; Laura Willen; Jasmine Coppens; An Spiessens; Basil Britto Xavier; Christine Lammens; Jan Verhaegen; Pierre Van Damme; Herman Goossens; Philippe Beutels; Veerle Matheeussen; Stefanie Desmet; Heidi Theeten; Surbhi Malhotra-Kumar
Journal:  Euro Surveill       Date:  2022-05

2.  What is the evidence for transmission of COVID-19 by children in schools? A living systematic review.

Authors:  Wei Xu; Xue Li; Marshall Dozier; Yazhou He; Amir Kirolos; Zhongyu Lang; Catherine Mathews; Nandi Siegfried; Evropi Theodoratou
Journal:  J Glob Health       Date:  2020-12       Impact factor: 4.413

Review 3.  The role of children in the transmission of SARS-CoV2: updated rapid review.

Authors:  Xue Li; Wei Xu; Marshall Dozier; Yazhou He; Amir Kirolos; Zhongyu Lang; Peige Song; Evropi Theodoratou
Journal:  J Glob Health       Date:  2020-12       Impact factor: 4.413

4.  Feasibility of SARS-CoV-2 Surveillance Testing Among Children and Childcare Workers at German Day Care Centers: A Nonrandomized Controlled Trial.

Authors:  Johannes Forster; Andrea Streng; Paul Rudolph; Viktoria Rücker; Julia Wallstabe; Sandra Timme; Franziska Pietsch; Katrin Hartmann; Maike Krauthausen; Julia Schmidt; Timo Ludwig; David Gierszewski; Thomas Jans; Geraldine Engels; Benedikt Weißbrich; Marcel Romanos; Lars Dölken; Peter Heuschmann; Christoph Härtel; Ildikó Gágyor; Marc Thilo Figge; Oliver Kurzai; Johannes Liese
Journal:  JAMA Netw Open       Date:  2022-01-04

5.  SARS-CoV-2 transmission in schools: An updated living systematic review (version 2; November 2020).

Authors:  Wei Xu; Xue Li; Yijia Dong; Marshall Dozier; Yazhou He; Amir Kirolos; Zhongyu Lang; Catherine Mathews; Nandi Siegfried; Evropi Theodoratou
Journal:  J Glob Health       Date:  2021-06-10       Impact factor: 4.413

6.  Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households, communities and educational settings: A systematic review and meta-analysis.

Authors:  Omar Irfan; Jiang Li; Kun Tang; Zhicheng Wang; Zulfiqar A Bhutta
Journal:  J Glob Health       Date:  2021-07-17       Impact factor: 4.413

7.  No SARS-CoV-2 carriage observed in children attending daycare centers during the intial weeks of the epidemic in Belgium.

Authors:  Stefanie Desmet; Esra Ekinci; Ine Wouters; Bram Decru; Kurt Beuselinck; Surbhi Malhotra-Kumar; Heidi Theeten
Journal:  J Med Virol       Date:  2020-12-17       Impact factor: 20.693

8.  The COVID-19 pandemic in children and young people during 2020-2021: Learning about clinical presentation, patterns of spread, viral load, diagnosis and treatment.

Authors:  Igor Rudan; Davies Adeloye; Srinivasa Vittal Katikireddi; Josie Murray; Colin Simpson; Syed Ahmar Shah; Chris Robertson; Aziz Sheikh
Journal:  J Glob Health       Date:  2021-12-25       Impact factor: 7.664

Review 9.  Transmission of SARS-CoV-2 by children: a rapid review, 30 December 2019 to 10 August 2020.

Authors:  Barbara Clyne; Karen Jordan; Susan Ahern; Kieran A Walsh; Paula Byrne; Paul G Carty; Linda Drummond; Kirsty K O'Brien; Susan M Smith; Patricia Harrington; Máirín Ryan; Michelle O'Neill
Journal:  Euro Surveill       Date:  2022-02

10.  Concordance in RT-PCR detection of SARS-CoV-2 between samples preserved in viral and bacterial transport medium.

Authors:  Bia Peña; Mayra Ochoa; Omar Flores; Ana I Gil; Lucie Ecker; Rubelio Cornejo; Claudio F Lanata; Leigh M Howard; Carlos G Grijalva
Journal:  J Virol Methods       Date:  2022-03-09       Impact factor: 2.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.